IN2014MU00185A - - Google Patents

Info

Publication number
IN2014MU00185A
IN2014MU00185A IN185MU2014A IN2014MU00185A IN 2014MU00185 A IN2014MU00185 A IN 2014MU00185A IN 185MU2014 A IN185MU2014 A IN 185MU2014A IN 2014MU00185 A IN2014MU00185 A IN 2014MU00185A
Authority
IN
India
Prior art keywords
linagliptin
metformin
pharmaceutical composition
composition
relates
Prior art date
Application number
Inventor
Venkataramana Naidu
Balasaheb Parshuram Wagh
Mohan L Krishna
Girish Kumar Jain
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN185MU2014 priority Critical patent/IN2014MU00185A/en
Priority to PCT/IB2015/050453 priority patent/WO2015110962A1/en
Publication of IN2014MU00185A publication Critical patent/IN2014MU00185A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to solid oral pharmaceutical composition comprising metformin and linagliptin or salt thereof. In particular, the present invention relates to solid oral stable pharmaceutical composition comprising fixed dose combination of metformin and linagliptin or salt thereof. By using an alkalizer, it is possible to achieve the stable pharmaceutical composition of metformin and linagliptin. The invention further relates to use of such composition in the treatment of diabetes mellitus. A method for the preparation of such composition is also described.
IN185MU2014 2014-01-21 2015-01-21 IN2014MU00185A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN185MU2014 IN2014MU00185A (en) 2014-01-21 2015-01-21
PCT/IB2015/050453 WO2015110962A1 (en) 2014-01-21 2015-01-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and linagliptin or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN185MU2014 IN2014MU00185A (en) 2014-01-21 2015-01-21

Publications (1)

Publication Number Publication Date
IN2014MU00185A true IN2014MU00185A (en) 2015-08-28

Family

ID=54393478

Family Applications (1)

Application Number Title Priority Date Filing Date
IN185MU2014 IN2014MU00185A (en) 2014-01-21 2015-01-21

Country Status (1)

Country Link
IN (1) IN2014MU00185A (en)

Similar Documents

Publication Publication Date Title
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
PH12017501033A1 (en) Oral care compositions and methods of use
MX2017005834A (en) Aadc polynucleotides for the treatment of parkinson's disease.
EA033544B1 (en) Pyridone derivatives as rearranged during transfection (ret) kinase inhibitors
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
PH12017500453B1 (en) Spirocyclic inhibitors of cathepsin c
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
MX2017005484A (en) Dopamine d3 receptor antagonists compounds.
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
EA201590364A1 (en) APPLICATION OF AIRWAY PERSON, HIS SALTS AND CRYSTALLINE FORMS AND COMPOSITIONS, ITS CONTAINING, FOR THE TREATMENT OF ZUD
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
CL2014002845A1 (en) Compounds derived from pyrazole sglt1 inhibitors; method to treat diabetes; pharmaceutical composition; use of the compound for the treatment of type 1 and type 2 diabetes.
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
EA201890209A1 (en) COMPOSITION CONTAINING TANINS
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
MX2018004774A (en) Substituted morpholine derivatives having activity against pain.
IN2014MU00184A (en)
IN2014MU00185A (en)
IN2014MU00187A (en)
IN2014MU00186A (en)
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
IN2014DN10683A (en)